Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotrol NS in Parkinson Disease
NCT03865121Phase 2Completed
- Sponsor
- National Institute of Neurology and Neurosurgery
- Start
- Mar 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Nicotrol NS in Parkinson's disease (PD), sponsored by National Institute of Neurology and Neurosurgery. Primary endpoint: Movement Disorder Society Unified Parkinson Disease Rating Scale Part III at 1 month. Started Mar 2019; status: completed.
02
Drugs
Nicotrol NS
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03865121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03865121.